DiscoverSquawk Pod
Squawk Pod
Claim Ownership

Squawk Pod

Author: CNBC

Subscribed: 555Played: 39,850


Squawk Pod is a daily, guided curation of the top moments and takeaways from CNBC’s flagship morning show, “Squawk Box”, anchored by Joe Kernen, Becky Quick and Andrew Ross Sorkin. Each day, the podcast includes news making interviews, perspective and analysis from iconic guest hosts, and slices of debate and discussion—from the heated to the hilarious— all wrapped with exclusive context and color from Senior Producer Katie Kramer.

371 Episodes
AstraZeneca’s Covid vaccine is the third one to prove highly effective in late-stage trials. AstraZeneca Executive Vice President Ruud Dobber explains differentiators of his company’s vaccine, and why between his company, Pfizer, and Moderna, he has high hopes for an accessible vaccine. New York Times columnist Thomas Friedman discusses the next steps in the race for a vaccine and in the Presidential transition. Plus, political pollster and strategist Frank Luntz unpacks what’s at stake on the ballots in Georgia.  Learn more about your ad choices. Visit
Pfizer is submitting its application to the FDA for emergency use of its Covid-19 vaccine. If approved, administration of the vaccine could begin before the end of the year. The FDA has approved emergency use of Eli Lilly’s arthritis drug baricitinib in combination with Gilead’s remdesivir to treat Covid-19 patients. Eli Lilly CEO David Ricks and CNBC’s Meg Tirrell discuss distribution, supply, and the path to approval for coronavirus treatments. Plus, IMAX CEO Richard Gelfond is planning ahead for theater reopenings around the world. He shares his own outlook for entertainment, in-person movies, and safety post-pandemic.  Learn more about your ad choices. Visit
David Boies, the lawyer who counseled former Vice President Al Gore in the 2000 election Florida recount, says President Trump will be unable to overturn the 2020 election results. Covid-19 cases are rising with hopes for an effective vaccine. In light of positive news from Pfizer, Moderna, and AstraZeneca, former Aetna CEO Mark Bertolini considers the current plans for managing supply and distribution and offers his own method as an alternative. SEC Chairman Jay Clayton is leaving his post after 3 years. In his exit interview on CNBC, he weighs in on cryptocurrency, the SPAC frenzy, and the next disruptors to the US financial system.  Learn more about your ad choices. Visit
As Covid cases rise and states impose new curfews to stem the spread, Pfizer & BioNtech have unveiled their coronavirus vaccine’s final data analysis. Their vaccine proved 95% effective in preventing the coronavirus, higher than preliminary data originally revealed. Former FDA Commissioner and Pfizer board member Dr. Scott Gottlieb discusses the bumpy but significantly shorter road to the end of the pandemic. He addresses next steps for lawmakers, Moderna, and Pfizer as they strategize vaccine supply and distribution. Plus, the Federal Aviation Administration has cleared the Boeing 737 Max to fly again, 20 months after it grounded the aircraft in the wake of two deadly crashes. In a CNBC exclusive interview, FAA Administrator Steve Dickson recounts the plane’s extensive safety reviews, discusses the journey ahead to restore confidence in the aircraft, and addresses concerns about his own agency’s relationship with Boeing.  Learn more about your ad choices. Visit
The S&P 500 will finally add Tesla to its index in mid-December. Elon Musk’s electric vehicle company now tops $400B in market cap. Warren Buffett’s Berkshire Hathaway made some changes to its equity portfolio in the last quarter, trimming its stakes in Apple and JPMorgan and betting on drug stocks and T-Mobile. Amazon is jumping into the pharmacy business with online prescription fulfillment and delivery for Prime members. Plus, conservative Americans may be seeking new media platforms; Newsmax CEO Christopher Ruddy responds to reports that his channel is a target for acquisition and defends his editorial perspective. Ruddy explains why his channel has become a Fox News alternative, and considers the prospect of “Trump TV.” Learn more about your ad choices. Visit
In Moderna’s ongoing clinical trial, the drugmaker’s Covid vaccine proved 94.5% effective in preventing the coronavirus. In an exclusive interview, CEO Stephane Bancel and CNBC’s Meg Tirrell discuss the news, the bright light at the end of the pandemic tunnel, and ensuring a steady supply of vaccines to those who need it most. Plus, former Citigroup chairman and former Time Warner CEO Richard Parsons considers what the vaccine would mean for American business, what a contested election would mean for the country’s future, and what the pandemic’s disruption to sports and entertainment will mean for media and content providers in the years to come.  Learn more about your ad choices. Visit
Social media entrepreneur and venture capitalist Alexis Ohanian urges Americans to consider the role social platforms should play in society. He examines where the Internet started, where it’s going, and how the “levers of power should be wielded.” He and Aylon Steinhart, founder of plant-based ice cream company Eclipse, outline a positive outlook for the startups and entrepreneurs who’ll emerge from the collective trauma and chaos of 2020. Restaurateur Cameron Mitchell operates over 30 establishments across the country, but he needs additional government stimulus to keep his business afloat. Plus, CNBC’s Robert Frank reports that the wealthy are hoping to pay for early access to Covid vaccines, and Elon Musk reports that his own Covid tests are testing his patience.  Learn more about your ad choices. Visit
Parler, a new social media platform that touts itself as a less censored alternative to Facebook and Twitter, is rising in popularity, particularly among conservative Americans. The Anti-Defamation League’s Jonathan Greenblatt says Parler’s free speech mission might be leaving too wide an opening for harmful content. Morgan Stanley’s Mike Wilson says this bull market has a long way to run, both in timing and pricing; he offers investors some cautionary advice. Plus, former FDA Commissioner Dr. Scott Gottlieb discusses rising Covid cases and the impact on the health care system across the nation. He considers the risks for Americans hoping to celebrate Thanksgiving in groups. Learn more about your ad choices. Visit
In a rare interview, Lyft co-founder and President John Zimmer discusses the ridesharing app’s path to profitability, plans for food delivery (or not), and a post-pandemic boost to business. Plus, the U.S. is celebrating and remembering veterans today; former CIA Director and retired U.S. Army general David Petraeus explains why it’s a good day to thank our servicemen and servicewomen, and an even better time to hire them. General Petraeus examines President-Elect Joe Biden’s campaign promise to “end never-ending wars,” and calls on history and geopolitical practice to imagine a world with less U.S. involvement in international conflict. Learn more about your ad choices. Visit
In the wake of Pfizer’s positive vaccine news, markets are rallying on hopes of a light at the end of the pandemic tunnel. BET and RLJ Companies founder Bob Johnson is relieved by the news but looking ahead; he discusses the pandemic’s disproportionate impact on Black Americans, and shares his vision for narrowing the racial health and wealth gap under a new administration. Plus, Target has entered a deal with Ulta Beauty, Amazon is in hot water in the EU, and Tesla is making up for defective computers in some of its vehicles.  Learn more about your ad choices. Visit
Ed Clissold, market strategist for Ned Davis Research Group, puts this week’s election in perspective with market and election data going back to 1900. Historically, a Republican incumbent victory prompts a market rally in the short term, but a reversal in the year following. Essayist and “Black Swan” investor Nassim Nicholas Taleb outlined the risks of a pandemic earlier in 2020, and now says the solution is simple, if only governments around the world could move past their coronavirus denial. Taleb - who advises Universa Investments, with 100%+ annual return from 2008-2019 - says victor predictions are a sign of incompetence; his election calculus: 50/50. Plus, Covid-19 cases continue to rise as we head into the holiday season. Learn more about your ad choices. Visit
In what Pfizer CEO Albert Bourla calls “likely the most significant medical advancement in the last 100 years,” BioNtech and Pfizer’s Covid-19 vaccine may prove to be more than 90% effective in preventing coronavirus. CNBC’s Senior Health and Science Reporter Meg Tirrell breaks the good news with the Squawk Box anchors, and Pfizer CEO Dr. Albert Bourla discusses the success, the implications, and the questions still unanswered. In an extended interview, Bourla thanks his scientists for their ongoing work to change the course of history and outlines the road ahead.  Learn more about your ad choices. Visit
Legendary investor Leon Cooperman explains his approach to markets amid the ongoing Presidential vote and the Federal Reserve’s approach to stabilizing the economy. The billionaire explains his personal vote for former Vice President Biden and his bet on equities. Uber CEO Dara Khosrowshahi unpacks his company’s latest financial results and his projection for a transportation recovery post-pandemic. In the wake of California’s Proposition 22 vote preserving gig workers’ status as contractors, Khosrowshahi considers what the measure will mean for the gig economy moving forward. Plus, as the final votes are counted, Harvard Professor, AEI President Emeritus, and contributing writer for The Atlantic Arthur Brooks says it’s time to rebuild the U.S., starting at home. The host of “The Art of Happiness with Arthur Brooks” encourages those who are pleased with the election outcome to reach out to their disappointed friends and family, to begin repairing the political division in America. Learn more about your ad choices. Visit
As 2020 election results trickle in, Al Gore’s running mate former Senator Joe Lieberman reflects on the 34 controversial days between Election Day in 2000 and Gore’s final concession. His lessons from that infamous election twenty years ago: at some point, for the good of the country, a peaceful transfer of power must ensue. Pollster and political strategist Frank Luntz considers what’s next for the candidates, the country, and his own polling profession. Whatever the outcome, Luntz says it’s only the beginning of America’s journey through political division. Plus, NYT’s Edmund Lee and Jefferies’ Brent Thill discuss what each administration would mean for big tech regulation.  Learn more about your ad choices. Visit
As votes are counted across the country, David Rubenstein, co-founder and co-executive chairman of The Carlyle Group, expects market jitters to continue until a clear winner emerges. He and IAC Chairman Barry Diller consider what political division in the U.S. means for the next four years of policy, business, international relations, and the American psyche, regardless of the election outcome. Diller reflects on liberal moral superiority, a potentially fatal flaw of the Democratic Party, and says that humility and respect are the keys to a hopeful future. Both Rubenstein and Diller agree that whatever his fate, Donald Trump is a political force to be respected and not dismissed.   Learn more about your ad choices. Visit
Election Day 2020 is finally here. At this culmination of America’s anxieties, former Facebook Chief Security Officer Alex Stamos discusses social media’s strategies and obligations to curb misinformation ahead of the final results. In a podcast original interview, The Wall Street Journal’s Joanna Stern shares how she found her anxiety fix in a social media blackout. Plus, regardless of the election outcome, Dr. Scott Gottlieb maps out a bumpy pandemic road ahead, and Joe, Becky, and Andrew consider the inevitability of civil unrest after all the votes are counted.  Learn more about your ad choices. Visit
Dr. Atul Gawande, Chairman of Haven, surgeon, and staff writer for The New Yorker, shares his expectations for coronavirus vaccine supply and American confidence in preventative drugs. CNBC’s Steve Liesman breaks down results from a CNBC All America Survey, revealing American faith in health care companies and the demographic disparities between those who are wary of and confident in a potential vaccine. Insider’s Henry Blodget unpacks the whirlwind week for tech and suggests that despite some disappointing quarterly reports, big tech will continue to deliver a strong performance for investors. Closing in on Election Day, CNBC’s Dominic Chu reveals how either administration would affect individual sectors.  Learn more about your ad choices. Visit
Ken Frazier, CEO of drug maker Merck, maps out his timeline for a coronavirus vaccine as cases continue to rise around the world. In a conversation with Yale School of Management’s Jeff Sonnenfeld, Frazier discusses the duty CEOs have to encourage voting, civility, and faith in the democratic process. Politics took precedence at big tech’s big (virtual) day on Capitol Hill. Former White House Chief Technology Officer Aneesh Chopra and CNBC’s Ylan Mui break down Jack Dorsey’s, Mark Zuckerberg’s, and Sundar Pichai’s four hour hearing before the Senate Commerce Committee. Plus, less than a week before the Presidential election with no end to the Covid pandemic in sight, the markets are struggling to find steady ground.  Learn more about your ad choices. Visit
Robinhood, the trading app that took young people and financiers by storm, now boasts 13 million user accounts. Its zero-commission trading model prompted an overhaul of the online brokerage ecosystem, although the company has run into SEC investigations, hackers, and performance outages along the way. In an extended interview with Andrew Ross Sorkin, CEO Vlad Tenev discusses the role Robinhood plays in the financial system and the risks and rewards of retail investors engaging in high volume trading. Tenev addresses wide ranging criticisms of his platform, and considers what’s next for the $11B-valued app.  Learn more about your ad choices. Visit
The National Institutes of Health has halted one of Eli Lilly’s coronavirus antibody trials, having found that the combination of Lilly’s antibody drug and Gilead’s remdesivir does not result in a marked improvement in hospitalized Covid-19 patients. Eli Lilly CEO David Ricks discusses what’s next for the antibody that’s proven successful in treating milder Covid cases, and he addresses the company’s third quarter financials. CNBC’s All America Survey reveals that while Joe Biden is leading President Trump in the election polls, both candidates must now rely on niche populations for victory. Senior Economics Reporter Steve Liesman unpacks the survey findings and shares which voting groups are crucial to which contender. Boston Consulting Group CEO Rich Lesser shares what c-suites are doing to encourage employee voting, and discusses how American CEOs may think about democracy going forward. Plus, the tech industry has thrown $200 million behind a campaign for California voters to support Proposition 22, the legislation that could preserve independent contractor status for gig economy workers.  Learn more about your ad choices. Visit
Comments (3)


The producer narrates WAAAY too much. I listen to this for the show, NOT Katie Cramer.

Aug 14th
Reply (1)


this podcast is so terrible. waaay too much narrator introduction and for no reason. it sucks up too much time. yes, I fast forward, but it's so annoying to even have to listen to "her" speak

May 12th
Download from Google Play
Download from App Store